. Author manuscript; available in PMC: 2016 Dec 1.

Published in final edited form as: Cytokine. 2015 Sep 11;76(2):328–333. doi: 10.1016/j.cyto.2015.09.003

Table 2.

Demographics^a

	All Subjects (n = 21)	Subjects without ARDS (n = 14)	Subjects with ARDS (n = 7)
Age (years)	40.7 ± 19.7	41.6 ± 20.6	39.0 ± 19.3
Gender (% male)	86	86	86
ISS	31 ± 11	33 ± 11	27 ± 10
Hospital LOS (days)	37.6 ± 18.8	28.8 ± 10.3	39.6 ± 26.7
ICU LOS (days)	20.6 ± 9.8	18 ± 7.0	20 ± 8.5
Admission until bronchoscopy (days)	6.6 ± 4.2	6.7 ± 3.3	6.4 ± 5.9
Pa0₂/Fi0₂ (P/F) Ratio	241 ± 94	278 ± 88	167 ± 55^*
Previous transfusion (days prior)	3.3 ± 2.7	3.3 ± 2.7	3.2 ± 2.7
Transfusion amount (units)	2.3 ± 0.9	2.2 ± 0.8	2.6 ± 1.1
Total In (liters)	27.1 ± 17.5	29.0 ± 15.8	23.3 ± 21.4
Fluid intake/outtake (I/O) balance (liters)	6.0 ± 5.3	6.0 ± 5.2	6.0 ± 6.0

The left-most column shows the demographics for all 21 enrolled subjects. Of these subjects, 14 did not have ARDS while 7 did have a diagnosis of ARDS. Data are expressed as mean ± SD.

p < 0.05 as w=compared with Subjects without ARDS.